Skip to main content
. 2022 Nov 21;33(5):905–915. doi: 10.1177/11207000221135068

Table 1.

Demographics, peri-operative data, complications and functional scores of patients reconstructed with a 3DPPI (n = 15).

Patient Sex Age (years) BMI (kg/m2) Follow-up (months) Histological diagnosis Malignant/Benign (M/B) (Neo-adjuvant) radiotherapy Enneking type resection Histological margins Surgical time (hours) Blood loss (ml) Henderson Implant related complications (treatment) Disease status MSTS HOOS-PS NRS rest NRS activity
Primary/Secondary (POB/POS/SIB*) Complication DFS/AWD/DOD**
Metastatic disease at presentation (Met) Classification
1 m 67.1 20.2 2.7 Renal cell carcinoma M/SIB y 2 + 3 Clear 6 9000 DOD na na na na
2 f 40.5 19.3 78.1 Osteosarcoma M/POB n 1 + 2 Clear 2.5 1500 DFS 87% 80% 0 0
3 m 72.2 25.4 34.4 Chondrosarcoma M/POB n 2 Clear 4.5 2000 DOD na na na na
4 m 71.8 26.6 36.3 Renal cell carcinoma M/SIB n 1 + 2 Clear 4.5 6000 DFS 57% 80% 0 1
5 m 20.6 17.0 59.7 Ewing sarcoma M/POB y 1 + 2 Clear 8 10,000 DFS 83% 91% 0 0
6 m 52.1 33.3 34.7 Renal cell carcinoma M/SIB n 2 + 3 Clear 8.5 7000 3a. 4a - Loose pubic screws (replacement)
-chronic infection (supressive antibiotics)
DFS 27% 44% 5 2
7 m 29.0 27.3 33.8 Chondrosarcoma M/POB n 2 + 3 Clear 8.5 10,000 1a -Hip dislocation (open reduction) DFS 63% 77% 0 3
8 f 31.0 21.2 23.9 Breast carcinoma M/SIB/Met y 1 + 2 + 3 Positive 5.5 6500 3a. 3a -Prominent flange (trimming)
-Srew S1 radiculopathy (replacement)
DOD na na na na
9 f 23.7 19.5 25.5 Neurofibroma B/POS n 2 Clear 3.5 1400 DFS 87% 80% 0 0
10 f 31.1 17.8 24.4 Osteosarcoma M/POB n 1 + 2 + 3 Clear 4.5 2400 DFS 47% 70% 0 2
11 m 40.2 20.7 17.0 Chondrosarcoma M/POB n 1 + 2 + 3 Clear 5.5 4000 5b -Tumour recurrence (hindquarter amputation) DOD na na na na
12 m 33.9 26.1 30.4 Testicular carcinoma M/SIB n 1 + 2 Clear 6 2000 DFS 63% 73% 5 7
13 m 38.0 30.7 27.3 Giant cell tumour of bone B/POB n 2 Clear 5 na DFS 43% 66% 3 7
14 f 22.6 18.6 45.7 Ewing sarcoma M/POB n 1 + 2 Clear 3 1400 DFS 63% 58% 0 5
15 f 16.0 18.6 44.0 Osteosarcoma M/POB n 2 Clear 4.5 na DFS 67% 70% 0 3
Median 33.9 20.7 33.8 5.5 5000 63% 77% 0 2
*

POB, primary of bone; POS, primary of soft tissue; SIB, secondary in bone.

**

DFS, disease free survival; AWD, alive with disease; DOD, died of disease.